Neurogene Inc. - Common Stock (NGNE)

Historical Holders from Q4 2023 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
NGNE on Nasdaq
Shares outstanding
15,392,157
Price per share
$20.60
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
15,298,947
Holdings value
$265,156,048
% of all portfolios
0%
Share change
-90,401
Value change
-$165,307
Average buys %
+0%
Average sells %
-0%
Number of holders
87
Price from insider filings
$15.15
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Neurogene Inc. - Common Stock (NGNE) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RTW INVESTMENTS, LP 10% $16,487,119 1,498,829 RTW Investments, LP 31 Dec 2024
Redmile Group, LLC 9.9% $16,277,426 1,479,766 Redmile Group, LLC 31 Dec 2024
EcoR1 Capital, LLC 9.9% $25,005,492 1,442,902 EcoR1 Capital, LLC 30 Sep 2025
Casdin Capital, LLC 8.7% $14,248,971 1,295,361 Casdin Capital, LLC 31 Dec 2024
BlackRock, Inc. 6.8% $11,125,796 1,011,436 BlackRock, Inc. 31 Mar 2025
BAKER BROS. ADVISORS LP 7% -30% $18,685,587 -$9,316,550 991,804 -33% Julian C. Baker 30 Jun 2025
Trails Edge Capital Partners, LP 5.1% $16,477,150 785,000 Trails Edge Capital Partners, LP 08 Dec 2025
FMR LLC 3.1% $5,091,669 462,879 FMR LLC 31 Mar 2025
GREAT POINT PARTNERS LLC 3% $4,870,371 442,761 Great Point Partners, LLC 31 Dec 2024
Commodore Capital LP 3% $8,060,995 427,866 Commodore Capital LP 30 Jun 2025
As of 30 Sep 2025, Neurogene Inc. - Common Stock (NGNE) has 87 institutional shareholders filing 13F forms. They hold 15,298,947 shares of 15,392,157 outstanding shares (99%) .

Top 25 institutional shareholders own 95% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
SAMSARA BIOCAPITAL, LLC 11% 1,717,127 0% 3.9% $29,757,811
RTW INVESTMENTS, LP 8.9% 1,362,456 0% 0.29% $23,611,362
Redmile Group, LLC 8.4% 1,299,022 +1.8% 2.2% $22,512,051
Casdin Capital, LLC 8.4% 1,295,361 0% 1.9% $22,448,606
EcoR1 Capital, LLC 8.3% 1,271,342 0% 1.1% $22,032,357
BAKER BROS. ADVISORS LP 6.4% 991,691 0% 0.12% $17,186,005
BlackRock, Inc. 6.2% 951,100 -2.7% 0% $16,482,563
Balyasny Asset Management L.P. 4.5% 699,002 0.02% $12,113,708
TORONTO DOMINION BANK 4.4% 681,337 0% 0.02% $11,807,570
VANGUARD GROUP INC 3.9% 604,611 -0.94% 0% $10,477,909
ArrowMark Colorado Holdings LLC 3.9% 595,839 +1.8% 0.19% $10,325,890
GREAT POINT PARTNERS LLC 2.9% 446,814 -8% 3.2% $7,743,287
MORGAN STANLEY 2.8% 426,576 -22% 0% $7,392,562
JENNISON ASSOCIATES LLC 2.6% 394,089 +135% 0% $6,829,562
Octagon Capital Advisors LP 1.6% 252,000 -17% 0.68% $4,367,160
MILLENNIUM MANAGEMENT LLC 1.6% 247,864 -19% 0% $4,295,483
GEODE CAPITAL MANAGEMENT, LLC 1.6% 246,433 -0.54% 0% $4,271,457
UBS Group AG 1.5% 227,716 -5.2% 0% $3,946,319
STATE STREET CORP 1.4% 208,310 -1.2% 0% $3,610,012
DEUTSCHE BANK AG\ 0.99% 152,284 +0.77% 0% $2,639,082
BLAIR WILLIAM & CO/IL 0.92% 141,820 +6.4% 0.01% $2,457,741
FMR LLC 0.75% 115,550 -75% 0% $2,002,482
Rock Springs Capital Management LP 0.68% 104,339 0% 0.11% $1,808,195
NORTHERN TRUST CORP 0.59% 90,098 -3.3% 0% $1,561,399
Woodline Partners LP 0.54% 83,835 0% 0.01% $1,452,861

Institutional Holders of Neurogene Inc. - Common Stock (NGNE) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 441 $9,085 -$2,245 $20.60 2
2025 Q3 15,298,947 $265,156,048 -$165,307 $17.33 87
2025 Q2 15,388,370 $230,113,281 -$13,642,152 $14.95 81
2025 Q1 16,456,922 $192,795,827 +$733,704 $11.71 83
2024 Q4 16,089,357 $367,798,844 +$14,465,355 $22.86 86
2024 Q3 13,847,659 $581,113,699 +$18,023,447 $41.96 85
2024 Q2 13,265,527 $482,740,885 +$37,444,033 $36.39 66
2024 Q1 12,128,797 $617,303,585 +$143,858,541 $50.90 58
2023 Q4 9,233,865 $178,953,482 +$172,259,940 $19.38 35